The stock of AstraZeneca PLC (NASDAQ:AZN) last traded at $71.28, up 1.14% from the previous session.
AZN stock price is now 1.11% away from the 50-day moving average and 3.80% away from the 200-day moving average. The market capitalization of the company currently stands at $220.52B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
A total of 0.50% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in AZN stock. A new stake in AstraZeneca PLC shares was purchased by CAPITAL RESEARCH GLOBAL INVESTORS during the first quarter worth $73,807,000. MANNING & NAPIER GROUP, LLC invested $51,676,000 in shares of AZN during the first quarter. In the first quarter, LMR PARTNERS LLP acquired a new stake in AstraZeneca PLC valued at approximately $43,825,000. CANOE FINANCIAL LP acquired a new stake in AZN for approximately $41,903,000. EXODUSPOINT CAPITAL MANAGEMENT, LP purchased a new stake in AZN valued at around $15,890,000 in the second quarter. In total, there are 1,297 active investors with 17.90% ownership of the company’s stock.
With an opening price of $70.89 on Wednesday morning, AstraZeneca PLC (NASDAQ: AZN) set off the trading day. During the past 12 months, AstraZeneca PLC has had a low of $52.65 and a high of $76.56. As of last week, the company has a debt-to-equity ratio of 0.80, a current ratio of 0.90, and a quick ratio of 0.70. According to the stock market information, the enterprise value for the company is $244.83B, which is based on a 36.09 price-to-earnings ratio, a 2.65 price-to-earnings-growth ratio, and a beta of 0.50. The fifty day moving average price for AZN is $70.47 and a two-hundred day moving average price translates $68.76 for the stock.
The latest earnings results from AstraZeneca PLC (NASDAQ: AZN) was released for Jun, 2023. According to the Drug Manufacturers – General Company, earnings per share came in at $1.08, beating analysts’ expectations of $0.95 by 0.13. This compares to $0.12 EPS in the same period last year. The net profit margin was 13.90% and return on equity was 17.00% for AZN. The company reported revenue of $11.42 billion for the quarter, compared to $10.77 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 5.99 percent. For the current quarter, analysts expect AZN to generate $11.68B in revenue.
Moreover, the firm recently paid out its quarterly dividend on 09/11/2023. Investors who held shares on 08/11/2023 were paid a $0.465 dividend. On an annualized basis, this represents a $1.45 dividend and a 2.03% percent yield. There was an ex-dividend date of 08/10/2023 for this dividend. In terms of dividend payout ratio, AZN is presently at 49.50%.
